Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Tachyarrhythmias in Microscopic Polyangitis Responding Well to Plasmapharesis Treatment

Hassan Tahir, Vistasp Daruwalla*

Department of Radiology, Wyne state University, Detroit Medical Center, Detroit Michigan, USA

Abstract: Microscopic polyangiitis (MPA) is a form of anti neutrophilic cytoplasmic antibody associated necrotizing vasculitis, which may present with a variety of clinical manifestations. Cardiac involvement in vaculitis is common and the manifestations usually include cardiomyopathy, pericarditis and arrhythmias. Our patient presented with dyspnea, hemoptysis and acute kidney injury. The patient developed frequent episodes of supraventricular tachycardia (SVT) and non-sustained ventricular tachycardia during the course of his stay, which subsequently resolved on treatment with plasmapheresis. Mortality rate is significantly high in patients with pulmonary hemorrhage and renal failure; plasmpheresis has proven to be beneficial in such acute case. Our case not only highlights the therapeutic effects of plasmapheresis on MPA but also stresses the importance of prompt plasmapheresis to mitigate MPA complications like SVT.

Keywords: microscopic polyangitis, plasmapharesis

Citation: Hassan Tahir, Vistasp Daruwalla, Tachyarrhythmias in Microscopic Polyangitis Responding Well to Plasmapharesis Treatment. American Journal of Medical Case Reports, 4 (7). 228-231. January 2016. doi:10.12691/ajmcr-4-7-2

1. Introduction

Microscopic polyangiitis (MPA) is a multi-systemic ANCA-associated vasculitis characterized by inflammation of small-sized vessels. Cardiac complications are commonly noted with MPA over the course of their disease. MPA usually presents with constitutional clinical features like dysnpea and acutre renal failure, which may worsen acutely with cardiac and neurovascular complications. Cardiac involvement like supraventricular tachycardiac (SVT) and pericarditis may dramatically worsen the prognosis and mortality in such patients. Circulating ANCAs, antiproteinase-3 (anti-PR3, c-ANCA), and anti-myeloperoxidase (anti-MPO, p-ANCA) have been reported to play a major role in the pathogenesis of ANCA associated small-vessel vasculitis; these antibodies are detectable in 70–90% cases and facilitate diagnosis [1], Our case demonstrates the effectiveness of plasmapheresis in attenuating the acute complications like SVT by elimination of circulating ANCA may stop the pathological process until corticosteroids and cyclophosphamide suppress inflammation and autoantibody production.

2. Case Presentation

A 73-year-old male with the past medical history of hypertension, prostate cancer status post prostatectomy, and chronic anemia presented to the emergency department with the complaints of worsening shortness of breath and leg swelling for 1 week. He was hemodynamically stable when he presented to ED, though he was in mild distress due to shortness of breath. His baseline investigations revealed hemoglobin of 7.2 g/dl, markedly high creatinine of 16.5 mg/dl and potassium of 6.3 meq/l. The 12-lead EKG did not show any ST or T-wave changes and 3 set of troponins were normal. Chest X ray showed bilateral pulmonary edema. He was given IV Lasix, 1 unit of packed RBC and 3 ampules (150 Meq) of bicarbonate. He underwent emergent hemodialysis for refractory hyperkalemia, acidosis and fluid overload, but his oxygen requirement increased with worsening shortness of breath and leg edema. In the mean time, patient developed massive hemoptysis and gross hematuria with acute blood loss anemia. He developed acute hypoxic respiratory failure for which he was intubated and admitted in the intensive care unit. The CT scan of the chest was ordered which showed extensive scattered ground-glass opacities throughout both lungs with probability of multifocal pneumonia (Figure 1). He was started on vancomycin and Zosyn for healthcare acquired pneumonia.

Due to his hemoptysis, hematuria and acute renal failure, ANCA vasculitis work up with renal biopsy was ordered. He was positive for anti myeloperoxidase antibodies (P-ANCA) and renal biopsy showed focal necrotizing and crescentic glomerulonephritis (RPGN pauci immune type) (Figure 2), thus supporting the diagnosis of microscopic polyangitis. Anti GBM antibody, ANA, C3 and C4 levels were normal, He was started on cyclophosphamide and steroids, but he continued to have hemoptysis with worsening blood loss anemia requiring frequent blood transfusions. In the mean time, he started having frequent episodes of non-sustained ventricular tachycardia (Figure 3) and supra ventricular tachycardia. He did not develop any symptoms during ventricular tachycardia episodes and SVT was treated with adenosine. His EKG did not show ischemic changes and troponins were again normal. His potassium, magnesium and calcium levels were with in normal limits. Transthoracic echocardiogram was ordered which showed ejection fraction of 65% with no valvular or wall motion abnormalities (Figure 4).

Figure 1. CT scan of the chest shows extensive scattered ground-glass opacities throughout both lungs

Figure 2. Renal Biopsy (H & E stain) shows focal necrotizing and crescentic glomerulonephritis

Figure 3. Non sustained ventricular tachycardia on rhythm strip

Figure 4. Transthoracic echocardiogram shows normal ejection fraction with no valvular or wall motion abnormalities

He was started on plasmapharesis treatment primarily for his pulmonary hemorrhage and renal failure, which resulted in improvement of kidney functions and pulmonary hemorrhage. His arrhythmias completely resolved with 2 sessions of plasmapharesis. No further arrhythmias were seen through out the remaining duration of his hospital stay. He was started on maintenance steroids and cyclophosphamide.

3. Discussion

Antineutrophil cytoplasmic autoantibody vasculitis like MPA and wegener’s granulomatosis are potentially fatal diseases secondary to multiorgan involvement. MPA commonly involves the pulmonary, renal and the integumentary system and is noted by ANCA positivity, pulmonary capillary inflammation and crescentic glomerulonephritis. Initial treatment with cyclophosphamide and prednisolone results in disease remission in about 80–90% of patients; however, those patients who present with advanced renal failure or pulmonary hemorrhage have significantly worse outcomes. Thus, in these patients stepwise introduction of more aggressive immunosuppressive induction therapy might be beneficial [2].

MPA often affects the heart in 10 to 20 % patients. Cardiovascular involvement in MPA may lead to congestive heart failure in 17.6% patients, pericarditis in 10% and subclinical myocardial infarctions. The myocardium is primarily affected due to vasculitis of coronary arterioles. Cardiac involvement may dramatically worsen the prognosis, particularly for MPA patients. Death can be caused by acute heart failure, arrhythmia or massive myocardial infarction, and can occur during the initial acute phase, or later during the course of the disease, due to refractory residual cardiac failure [3]. Occasionally heart disease can be secondary to uncontrolled hypertension secondary MPA. A case of cardiac tamponade secondary to acute necrotic inflammation by MPA has been reported [4]. While aortic valve insufficiency due to large vessel involvement in MPA without relative endocarditis have also been noted in the literature [5].

MPA without prompt treatment carries a very high mortality, with a 5-year survival of 10% to 20%. Renal failure and acute pulmonary hemorrhage are the leading cause of mortalityin such patients. High dose steroids and cyclophosphamide are usually the first line of treatment and can greatly improve the prognosis. Other medications have been used including methotrexate, azathioprine, TNF alpha blockers, rituximab, mycophenolate mofetil, IVIG. Maintenance therapy is required after successful induction, although the optimal duration is not clear [4].

Plasmapheresis has been shown to be effective in removal of circulating antibodies which assists in resolving the acute complications and further deterioration of the patient’s condition. Plasmapheresis facilitates rapid restoration of the renal function without complications. The combination of plasmapheresis with immunosuppressive medication adds much to the recovery of renal function in cases with serious acute renal failure. Plasmapheresis should be considered for all patients with severe alveolar hemorrhage, those with increasing hemoptysis despite conventional immunosuppressive treatment, and those with advanced renal failure (creatinine >5.7 mg/dL and/or the need for hemodialysis) [6].

Our case demonstrates the typical presentation of MPA developing cardiac conduction defects as acute complication of MPA, which was successfully treated with a combination of oral steroids, cyclophosphamide therapy and plasmapheresis. Although the efficacy of plasmapheresis compared to systemic drug therapy is debatable, plasmapheresis provides acute relief in cardiac and pulmonary complications. It also assists in rapid recovery of renal function covering the lag time period the systemically administered corticosteroids and immunosuppressive agents need to be effective, hence plasmapheresis should be considered as an adjunctive therapy for MPA. Plasmapheresis might also be a useful in patients with MPA who are not responding to standard therapy. This case shows that early diagnosis and interventions like plasmapheresis is crucial in vasculitis associated glomerulonephritis and can reverse cardiac complications like SVT and VT. The primary reason for plasmapharesis in out patient was severe pulmonary hemorrhage and renal failure, though it also resolved cardiac arrhythmias in our patient.

4. Conclusion

Acute cardiac arrhythmias secondary to MPA may prove to be life threatening and lead to increased mortality. Immunosuppressive therapy along with prompt plasmapheresis must be considered in patients with acute renal failure and diffuse alveolar hemorrhage. The fact that plasmapharesis resolved arrhythmias in our patient indicate that plasmapharesis might be a treatment option in vasculitis patients presenting with life threatening cardiac arrhythmias. Our case highlights the rapid therapeutic effects demonstrated by plasmapheresis and emphasizes its utility in providing adequate protection at a critical time.

References

[1]   | Wang CC1, Shiang JC, Tsai MK, Chen IH, Lin SH, Chu P, Wu CC. Prompt plasmapheresis successfully rescue pulmonary-renal syndrome caused by ANCA negative microscopic polyangiitis. Clin Rheumatol. 2009 Dec; 28(12):1457-60.
[2]   | De Joode AA1, Sanders JS, Smid WM, Stegeman CA. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression. J Clin Apher. 2014 Oct; 29(5): 266-72.
[3]   | Pagnoux C1, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus. 2005; 14(9): 718-22.
[4]   | Kaur P1, Palya A, Hussain H, Dabral S. Microscopic polyangiitis presenting as early cardiac tamponade. J Clin Rheumatol. 2010 Mar; 16(2): 86-7.
[5]   | Kim BK1, Park SY, Choi CB, Kim TH, Jun JB, Jang SM, Park MH, Uhm WS. A case of microscopic polyangiitis associated with aortic valve insufficiency. Rheumatol Int. 2013 Apr; 33(4): 1055-8.
[6]   | Aydin Z1, Gursu M, Karadag S, Uzun S, Tatli E, Sumnu A, Ozturk S, Kazancioglu R. Role of plasmapheresis performed in hemodialysis units for the treatment of anti-neutrophilic cytoplasmic antibody-associated systemic vasculitides. Ther Apher Dial. 2011 Oct; 15(5): 493-8.